Abstract
BACKGROUND: Puerperal sepsis due to group A beta-hemolytic streptococcal (GAS) toxic shock syndrome is associated with very high morbidity and mortality. Luckily it is now rare, but diagnosis is not always easy. This report demonstrates the problem of recognizing this disease, and summarizes the current knowledge on the pathomechanism and management of streptococcal toxic shock syndrome. CASE: Two cases of postpartum streptococcal toxic shock syndrome due to GAS are described. In both cases the correct diagnosis was delayed for several days. The first patient was sent home with the diagnosis of German measles; the second patient was transferred to our neurological intensive care unit with the diagnosis of meningitis. Both patients were admitted to the intensive care unit in profound shock, both developed multiple organ failure, and one patient died. CONCLUSIONS: GAS may produce virulence factors that cause host tissue pathology. Besides aggressive modern intensive care treatment, early diagnosis and correct choice of anti-streptococcal antibiotics are crucial. A possible adverse effect of non-steroidal anti-inflammatory agents requires confirmation in a multicenter study.
Full Text
The Full Text of this article is available as a PDF (239.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bohach G. A., Fast D. J., Nelson R. D., Schlievert P. M. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol. 1990;17(4):251–272. doi: 10.3109/10408419009105728. [DOI] [PubMed] [Google Scholar]
- Bone R. C., Sibbald W. J., Sprung C. L. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest. 1992 Jun;101(6):1481–1483. doi: 10.1378/chest.101.6.1481. [DOI] [PubMed] [Google Scholar]
- Davies H. D., McGeer A., Schwartz B., Green K., Cann D., Simor A. E., Low D. E. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med. 1996 Aug 22;335(8):547–554. doi: 10.1056/NEJM199608223350803. [DOI] [PubMed] [Google Scholar]
- Hackett S. P., Stevens D. L. Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis. 1992 May;165(5):879–885. doi: 10.1093/infdis/165.5.879. [DOI] [PubMed] [Google Scholar]
- Knaus W. A., Draper E. A., Wagner D. P., Zimmerman J. E. APACHE II: a severity of disease classification system. Crit Care Med. 1985 Oct;13(10):818–829. [PubMed] [Google Scholar]
- Marshall J. C., Cook D. J., Christou N. V., Bernard G. R., Sprung C. L., Sibbald W. J. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995 Oct;23(10):1638–1652. doi: 10.1097/00003246-199510000-00007. [DOI] [PubMed] [Google Scholar]
- Schlievert P. M. Role of superantigens in human disease. J Infect Dis. 1993 May;167(5):997–1002. doi: 10.1093/infdis/167.5.997. [DOI] [PubMed] [Google Scholar]
- Sriskandan S., Kemball-Cook G., Moyes D., Canvin J., Tuddenham E., Cohen J. Contact activation in shock caused by invasive group A Streptococcus pyogenes. Crit Care Med. 2000 Nov;28(11):3684–3691. doi: 10.1097/00003246-200011000-00025. [DOI] [PubMed] [Google Scholar]
- Stegmayr B., Björck S., Holm S., Nisell J., Rydvall A., Settergren B. Septic shock induced by group A streptococcal infection: clinical and therapeutic aspects. Scand J Infect Dis. 1992;24(5):589–597. doi: 10.3109/00365549209054644. [DOI] [PubMed] [Google Scholar]
- Stevens D. L. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis. 1995 Oct;21(4):977–980. doi: 10.1093/clinids/21.4.977. [DOI] [PubMed] [Google Scholar]
- Stevens D. L., Gibbons A. E., Bergstrom R., Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis. 1988 Jul;158(1):23–28. doi: 10.1093/infdis/158.1.23. [DOI] [PubMed] [Google Scholar]
- Stevens D. L. Invasive group A streptococcal infections: the past, present and future. Pediatr Infect Dis J. 1994 Jun;13(6):561–566. doi: 10.1097/00006454-199406000-00033. [DOI] [PubMed] [Google Scholar]
- Stevens D. L. Invasive group A streptococcus infections. Clin Infect Dis. 1992 Jan;14(1):2–11. doi: 10.1093/clinids/14.1.2. [DOI] [PubMed] [Google Scholar]
- Stevens D. L. Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome. Clin Infect Dis. 1998 Mar;26(3):639–641. doi: 10.1086/514585. [DOI] [PubMed] [Google Scholar]